Sydni Johnston, Associate Director at Cardinal Health Sonexus™ Access and Patient Support, explains how manufacturers can ...

While advances in cell & gene therapy continue to show promise for creating new treatments, this sector of the industry still ...

In today’s Pharmaceutical Executive Daily, Sanofi formally confirms its CEO leadership following a shareholder vote, US ...

Shareholder approval positions Garijo to steer strategy toward operational rigor, portfolio discipline, and more consistent ...

GLP-1 agonists have become the dominant spend catalyst, with class spending ~$132B and growth contribution approaching ...

Advanced analytics are positioned to move hub operations from retrospective reporting to predictive identification of delay ...

RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...

The Strait of Hormuz is one of the world’s most critical transit points; 20% to 25% of global maritime oil trade flows ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

In a conversation with Pharmaceutical Executive at Asembia’s AXS26 Summit, Kim Plesnarski, vice president, strategic market ...

Rare Pediatric Disease PRVs can accelerate FDA review timelines for another asset, and their resale market creates a tangible ...

In the first part of his interview, Jeff Golfman, notes how The Strait of Hormuz disruption exposes broader global supply ...